Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis.

Fogarty, Emer; Schmitz, Susanne; Tubridy, Niall; Walsh, Cathal; Barry, Michael

Fogarty, Emer; Schmitz, Susanne; Tubridy, Niall; Walsh, Cathal; Barry, Michael.

Afiliação

Fogarty E; National Centre for Pharmacoeconomics, Dublin, Ireland. Electronic address: efogarty@stjames.ie.
Schmitz S; Health Economics and Evidence Synthesis Research Unit, Department of Population Health, Luxembourg Institute of Health, Luxembourg.
Tubridy N; Department of Neurology, St. Vincent's University Hospital, Dublin, Ireland.
Walsh C; Department of Mathematics and Statistics, University of Limerick, Ireland.
Barry M; National Centre for Pharmacoeconomics, Dublin, Ireland.

Mult Scler Relat Disord ; 9: 23-30, 2016 Sep.

Article em En | MEDLINE | ID: mdl-27645339

Assuntos

Esclerose Múltipla Recidivante-Remitente/tratamento farmacológico; Humanos; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

Disability progression; Disease-modifying therapy; Multiple sclerosis; Network meta-analysis; Relapse; Systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google